CPA6, FMO2, LGI1, SIAT1 and TNC are differentially expressed in early- and late-stage oral squamous cell carcinoma - A pilot study

Oral Oncology

Volumn 44, Issue 10, 2008, Pages 941-948

  Fialka, Florian ^a   Gruber, Rudolf Matthias ^a   Hitt, Reiner ^a   Opitz, Lennart ^a   Brunner, Edgar ^a   Schliephake, Henning ^a   Kramer, Franz Josef ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Cancer; CPA6; FMO2; Gene expression; LGI1; Microarray; Oral squamous cell carcinoma; OSCC; Real time PCR; SIAT1; TNC

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CANCER STAGING; CARBOXYPEPTIDASE A6 GENE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLAVIN CONTAINING MONOOXYGENASE 2 GENE; GENE; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; LEUCINE RICH GLIOMA INACTIVATED PROTEINE 1 GENE; MALE; MICROARRAY ANALYSIS; MOUTH CARCINOMA; PILOT STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIALYLTRANSFERASE 1 GENE; SQUAMOUS CELL CARCINOMA; TENASCIN GENE; TUMOR BIOPSY; TUMOR GROWTH;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; CARBOXYPEPTIDASES A; CARCINOMA, SQUAMOUS CELL; FEMALE; FROZEN SECTIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM PROTEINS; NEOPLASM STAGING; OXYGENASES; PILOT PROJECTS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIALYLTRANSFERASES; TENASCIN; UP-REGULATION;

EID: 51749119672     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2007.10.011     Document Type: Article

References (53)

1. Jemal A., Tiwari R.C., Murray T., Ghafoor A., Samuels A., Ward E., et al. Cancer statistics, 2004. CA Cancer J Clin 54 1 (2004) 8-29
2. Parkin D.M., Pisani P., and Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80 6 (1999) 827-841
3. Wenzel S., Sagowski C., Kehrl W., and Metternich F.U. The prognostic impact of metastatic pattern of lymph nodes in patients with oral and oropharyngeal squamous cell carcinomas. Eur Arch Otorhinolaryngol 261 5 (2004) 270-275
4. Estilo C.L., P O.C., Ngai I., Patel S.G., Reddy P.G., Dao S., et al. The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110α in squamous cell carcinoma of the oral tongue. Clin Cancer Res 9 6 (2003) 2300-2306
5. Kouzu Y., Uzawa K., Koike H., Saito K., Nakashima D., Higo M., et al. Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis. Bri J Cancer 94 5 (2006) 717-723
6. Cromer A., Carles A., Millon R., Ganguli G., Chalmel F., Lemaire F., et al. Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis. Oncogene 23 14 (2004) 2484-2498
7. Chung C.H., Parker J.S., Karaca G., Wu J., Funkhouser W.K., Moore D., et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 5 5 (2004) 489-500
8. Nagata M., Fujita H., Ida H., Hoshina H., Inoue T., Seki Y., et al. Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis. Int J Cancer 106 5 (2003) 683-689
9. Warner G.C., Reis P.P., Jurisica I., Sultan M., Arora S., Macmillan C., et al. Molecular classification of oral cancer by cDNA microarrays identifies overexpressed genes correlated with nodal metastasis. Int J Cancer 110 6 (2004) 857-868
10. Lo Muzio L., Santarelli A., Emanuelli M., Pierella F., Sartini D., Staibano S., et al. Genetic analysis of oral squamous cell carcinoma by cDNA microarrays focused apoptotic pathway. Int J Immunopathol Pharmacol 19 3 (2006) 675-682
11. Chin D., Boyle G.M., Williams R.M., Ferguson K., Pandeya N., Pedley J., et al. Novel markers for poor prognosis in head and neck cancer. Int J Cancer 113 5 (2005) 789-797
12. Robbins K.T., Medina J.E., Wolfe G.T., Levine P.A., Sessions R.B., and Pruet C.W. Standardizing neck dissection terminology. Official report of the Academy's Committee for head and neck surgery and oncology. Arch Otolaryngol-Head Neck Surgery 117 6 (1991) 601-605
13. Gellrich N.C., Schramm A., Bockmann R., and Kugler J. Follow-up in patients with oral cancer. J Oral Maxillofac Surg 60 4 (2002) 380-386 discussion 387-388
14. Landgrebe J., Bretz F., and Brunner E. Efficient two-sample designs for microarray experiments with biological replications. In Silico Biol 4 4 (2004) 461-470
15. Katzer M. Automatisches Segmentieren von Mikroarraybildern [Ingenieurswissenschaftliche Dissertation] (2004), Technische Fakultät, Universität Bielefeld, Bielefeld
16. Yang Y.H., Dudoit S., Luu P., Lin D.M., Peng V., Ngai J., et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 30 4 (2002) e15
17. Cleveland W. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 74 368 (1979) 829-836
18. Bretz F., Landgrebe J., and Brunner E. Multiplicity issues in microarray experiments. Methods Inform Med 44 3 (2005) 431-437
19. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Statistical Soc: Series B (Methodol) 57 1 (1995) 289-300
20. Dolphin C.T., Shephard E.A., Povey S., Smith R.L., and Phillips I.R. Cloning, primary sequence and chromosomal localization of human FMO2, a new member of the flavin-containing mono-oxygenase family. Biochem J 287 Pt 1 (1992) 261-267
21. Shehin-Johnson S.E., Williams D.E., Larsen-Su S., Stresser D.M., and Hines R.N. Tissue-specific expression of flavin-containing monooxygenase (FMO) forms 1 and 2 in the rabbit. J Pharmacol Experimental Therapeutics 272 3 (1995) 1293-1299
22. Zhang J., and Cashman J.R. Quantitative analysis of FMO gene mRNA levels in human tissues. Drug Metabolism Disposition: Biological Fate Chemicals 34 1 (2006) 19-26
23. Zhao H., Langerod A., Ji Y., Nowels K.W., Nesland J.M., Tibshirani R., et al. Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol Biol Cell 15 6 (2004) 2523-2536
24. Bashyam M.D., Bair R., Kim Y.H., Wang P., Hernandez-Boussard T., Karikari C.A., et al. Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer. Neoplasia (New York, NY) 7 6 (2005) 556-562
25. Chiquet M., and Fambrough D.M. Chick myotendinous antigen I. A monoclonal antibody as a marker for tendon and muscle morphogenesis. J Cell Biol 98 6 (1984) 1926-1936
26. Chiquet-Ehrismann R., Mackie E.J., Pearson C.A., and Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell 47 1 (1986) 131-139
27. Zhao M., Laissue J.A., and Zimmermann A. Tenascin and type IV collagen expression in liver cell dysplasia and in hepatocellular carcinoma. Histology Histopathol 11 2 (1996) 323-333
28. Ikeda Y., Mori M., Kajiyama K., Haraguchi Y., Sasaki O., and Sugimachi K. Immunohistochemical expression of tenascin in normal stomach tissue, gastric carcinomas and gastric carcinoma in lymph nodes. Bri J Cancer 72 1 (1995) 189-192
29. Soini Y., Paakko P., Nuorva K., Kamel D., Linnala A., Virtanen I., et al. Tenascin immunoreactivity in lung tumors. Am J Clin Pathol 100 2 (1993) 145-150
30. Dandachi N., Hauser-Kronberger C., More E., Wiesener B., Hacker G.W., Dietze O., et al. Co-expression of tenascin-C and vimentin in human breast cancer cells indicates phenotypic transdifferentiation during tumour progression: correlation with histopathological parameters, hormone receptors, and oncoproteins. J Pathol 193 2 (2001) 181-189
31. Hauptmann S., Zardi L., Siri A., Carnemolla B., Borsi L., Castellucci M., et al. Extracellular matrix proteins in colorectal carcinomas. Expression of tenascin and fibronectin isoforms. Lab Invest J Tech Methods Pathol 73 2 (1995) 172-182
32. Beiter K., Hiendlmeyer E., Brabletz T., Hlubek F., Haynl A., Knoll C., et al. β-Catenin regulates the expression of tenascin-C in human colorectal tumors. Oncogene 24 55 (2005) 8200-8204
33. Harada T., Shinohara M., Nakamura S., and Oka M. An immunohistochemical study of the extracellular matrix in oral squamous cell carcinoma and its association with invasive and metastatic potential. Virchows Arch 424 3 (1994) 257-266
34. Lee S.K., Park S.C., Chi J.G., Sakamoto F., Shrestha P., and Mori M. Expression of tenascin in hamster buccal pouch mucosa during experimental carcinogenesis. Eur J Cancer 31B 3 (1995) 188-192
35. Atula T., Hedstrom J., Finne P., Leivo I., Markkanen-Leppanen M., and Haglund C. Tenascin-C expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma. Anticancer Res 23 3C (2003) 3051-3056
36. Berndt A., Borsi L., Hyckel P., and Kosmehl H. Fibrillary co-deposition of laminin-5 and large unspliced tenascin-C in the invasive front of oral squamous cell carcinoma in vivo and in vitro. J Cancer Res Clin Oncol 127 5 (2001) 286-292
37. Petretti T., Kemmner W., Schulze B., and Schlag P.M. Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases. Gut 46 3 (2000) 359-366
38. Recchi M.A., Hebbar M., Hornez L., Harduin-Lepers A., Peyrat J.P., and Delannoy P. Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. Cancer Res 58 18 (1998) 4066-4070
39. Wang P.H., Li Y.F., Juang C.M., Lee Y.R., Chao H.T., Tsai Y.C., et al. Altered mRNA expression of sialyltransferase in squamous cell carcinomas of the cervix. Gynecol Oncol 83 1 (2001) 121-127
40. Fukushima K., Hara-Kuge S., Seko A., Ikehara Y., and Yamashita K. Elevation of α → 6 sialyltransferase and α → 2 fucosyltransferase activities in human choriocarcinoma. Cancer Res 58 19 (1998) 4301-4306
41. Bresalier R.S., Ho S.B., Schoeppner H.L., Kim Y.S., Sleisenger M.H., Brodt P., et al. Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis. Gastroenterology 110 5 (1996) 1354-1367
42. Poon T.C., Chiu C.H., Lai P.B., Mok T.S., Zee B., Chan A.T., et al. Correlation and prognostic significance of beta-galactoside alpha-2,6-sialyltransferase and serum monosialylated alpha-fetoprotein in hepatocellular carcinoma. World J Gastroenterol 11 42 (2005) 6701-6706
43. Yamamoto H., Oviedo A., Sweeley C., Saito T., and Moskal J.R. α2,6-Sialylation of cell-surface N-glycans inhibits glioma formation in vivo. Cancer Res 61 18 (2001) 6822-6829
44. Wei S., Segura S., Vendrell J., Aviles F.X., Lanoue E., Day R., et al. Identification and characterization of three members of the human metallocarboxypeptidase gene family. J Biol Chem 277 17 (2002) 14954-14964
45. Fontenele-Neto J.D., Kalinina E., Feng Y., and Fricker L.D. Identification and distribution of mouse carboxypeptidase A-6. Brain Res 137 1-2 (2005) 132-142
46. Chernova O.B., Somerville R.P., and Cowell J.K. A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors. Oncogene 17 22 (1998) 2873-2881
47. Fujimoto M., Fults D.W., Thomas G.A., Nakamura Y., Heilbrun M.P., White R., et al. Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme. Genomics 4 2 (1989) 210-214
48. Kobe B., and Deisenhofer J. Proteins with leucine-rich repeats. Curr Opinion Structural Biol 5 3 (1995) 409-416
49. Brodtkorb E., Nakken K.O., and Steinlein O.K. No evidence for a seriously increased malignancy risk in LGI1-caused epilepsy. Epilepsy Res 56 2-3 (2003) 205-208
50. Steinlein O.K. Genetic mechanisms that underlie epilepsy. Nature Rev 5 5 (2004) 400-408
51. Piepoli T., Jakupoglu C., Gu W., Lualdi E., Suarez-Merino B., Poliani P.L., et al. Expression studies in gliomas and glial cells do not support a tumor suppressor role for LGI1. Neuro-oncology 8 2 (2006) 96-108
52. Sakakura K., Chikamatsu K., Sakurai T., Takahashi K., Murata T., Oriuchi N., et al. Infiltration of dendritic cells and NK cells into the sentinel lymph node in oral cavity cancer. Oral Oncol 41 1 (2005) 89-96
53. Reichert T.E., Scheuer C., Day R., Wagner W., and Whiteside T.L. The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma. Cancer 91 11 (2001) 2136-2147